Nutrition
Volume 26, Issue 3 , Pages 276-282 , March 2010

Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease

  • Shou-Shan Chiang, M.D.

      Affiliations

    • Department of Internal Medicine/Nephrology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
    • ,
  • Cheng-Wei Tai, M.S.

      Affiliations

    • School of Public Health, Taipei Medical University, Taipei, Taiwan
    • ,
  • Chi-Jung Chung, M.S.

      Affiliations

    • School of Public Health, Taipei Medical University, Taipei, Taiwan
    • ,
  • Horng-Sheng Shiue, M.D.

      Affiliations

    • Department of Chinese Medicine, Chang Gung Memorial Hospital, and Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
    • ,
  • Jin-Bor Chen, M.D.

      Affiliations

    • Nephrology Division, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Kaohsiung, Taiwan
    • ,
  • Chien-Tien Su, M.D.

      Affiliations

    • Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan
    • ,
  • Yu-Mei Hsueh, Ph.D.

      Affiliations

    • Department of Public Health, School of Medicine, Taipei Medical University, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886-2-2736-1661, ext. 6513; fax: +886-2-2738-4831.

Received 16 November 2008 ,Accepted 25 April 2009.

References 

  1. Lee YT, Chiu HC, Su HM, Yang JF, Voon WC, Lin TH, et al. Lower hemoglobin concentrations and subsequent decline in kidney function in an apparently healthy population aged 60 year and older. Clin Chim Acta. 2008;389:25–30
  2. Hsu CC, Bray MS, Kao WH, Pankow JS, Boerwinkle E, Coresh J. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. J Am Soc Nephrol. 2006;17:504–512
  3. Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of chronic kidney disease. Semin Dial. 2007;20:229–236
  4. Higashikuni Y, Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Relationship between blood pressure and chronic kidney disease in the Japanese population: the lower the better even in individuals without hypertension?. Hypertens Res. 2008;31:213–219
  5. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14:2934–2941
  6. Agodoa LY, Francis ME, Eggers PW. Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults. Am J Kidney Dis. 2008;51:573–583
  7. Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164:1519–1524
  8. Olaleye MT, Rocha BT. Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system. Exp Toxicol Pathol. 2008;59:319–327
  9. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 2004;13:93–99
  10. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol. 2008;19:593–599
  11. Markovitch D, Tyrrell RM, Tauler P, Frystyk J, Stokes K, Thompson D. Lycopene supplementation (passata sauce) reduces apoptosis but does not affect oxidant-responsive heme oxygenase-1 in human lymphocytes. Nutrition. 2009;25:668–675
  12. Jacob K, Periago MJ, Bohm V, Berruezo GR. Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr. 2008;99:137–146
  13. Basu TK, Schorah CL. Vitamin C reserves and requirements in health and disease. In:  Basu TK,  Schorah CS editor. Vitamin C in health and disease. London: Croom Helm; 1982;p. 62–92
  14. Hadley CW, Clinton SK, Schwartz SJ. The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr. 2003;133:727–732
  15. National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  16. Miller KW, Lorr NA, Yang CS. Simultaneous determination of plasma retinol, alpha-tocopherol, lycopene, alpha-carotene, and beta-carotene by high-performance liquid chromatography. Anal Biochem. 1984;138:340–345
  17. Rothman KJ. Modern epidemiology. Boston, MA: Litter Brown and Company; 1986;p. 322–6
  18. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3:452–456
  19. Chou CY, Cheng SY, Liu JH, Cheng WC, Kang IM, Tseng YH, et al. Association between betel-nut chewing and chronic kidney disease in men. Public Health Nutr. 2008;12:1–5
  20. Chou CY, Lin CH, Lin CC, Huang CC, Liu CS, Lai SW. Association between waist-to-hip ratio and chronic kidney disease in the elderly. Intern Med J. 2008;38:402–406
  21. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial. 2004;17:365–370
  22. USRDS . United States renal data system—excerpts from the 2003 data report. Am J Kidney Dis. 2003;42(suppl 5):S1–S230
  23. Presti RL, Carollo C, Caimi G. Wine consumption and renal diseases: new perspectives. Nutrition. 2007;23:598–602
  24. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371:2173–2182
  25. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  26. Bohm F, Tinkler JH, Truscott TG. Carotenoids protect against cell membrane damage by the nitrogen dioxide radical. Nat Med. 1995;1:98–99
  27. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer. 1998;31:199–203
  28. Martin KR, Wu D, Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis. 2000;150:265–274
  29. Abahusain MA, Al-Nahedh NN. The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes. Saudi J Kidney Dis Transpl. 2002;13:18–23
  30. Jaconi S, Saurat JH, Siegenthaler G. Analysis of normal and truncated holo- and apo-retinol-binding protein (RBP) in human serum: altered ratios in chronic renal failure. Eur J Endocrinol. 1996;134:576–582
  31. Glover J, Moxley L, Muhilal H, Weston S. Micromethod for fluorimetric assay of retinol-binding protein in blood–plasma. Clin Chim Acta. 1974;50:371–380
  32. Bernard A, Vyskocyl A, Mahieu P, Lauwerys R. Effect of renal-insufficiency on the concentration of free retinol-binding protein in urine and serum. Clin Chim Acta. 1988;171:85–93
  33. Cabre A, Lazaro I, Girona J, Manzanares J, Marimon F, Plana N, et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med. 2007;262:496–503
  34. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, et al. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care. 2007;30:2588–2592
  35. Papavasileiou V, Liakopoulos V, Sakkas GK, Hadjigeorgiou GM, Koukoulis G, Stefanidis I. Serum levels of adipokine retinol-binding protein-4 in relation to renal function: response to Ziegelmeier et al. Diabetes Care. 2008;31:e23
  36. Henrich WL, Clark RL, Kelly JP, Buckalew VM, Fenves A, Finn WF, et al. Non–contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study. J Am Soc Nephrol. 2006;17:1472–1480
  37. Sandler DP, Smith JC, Weinberg CR, Buckalew VM, Dennis VW, Blythe WB, et al. Analgesic use and chronic renal disease. N Engl J Med. 1989;320:1238–1243
  38. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331:1675–1679
  39. Lipton RB, Raskin N, Ruoff G, Saper J, Sheftell F, Solomon S. Over-the-counter analgesics and kidney disease. Am J Kidney Dis. 1996;27:917–918
  40. Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol. 2006;2:80–91
  41. Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD. Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med. 2001;31:139–152

 The study was supported by grant SKH-TMU-95-23 from Shin Kong Wu Ho-Su Memorial Hospital and Taipei Medical University in Taipei, Taiwan.

PII: S0899-9007(09)00211-1

doi: 10.1016/j.nut.2009.04.021

Nutrition
Volume 26, Issue 3 , Pages 276-282 , March 2010

Article Tools

* Image Usage & Resolution